Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance
PTH resistance is characterized by elevated parathyroid hormone (PTH) levels, hypocalcemia, hyperphosphatemia and it is classically associated with GNAS locus genetic or epigenetic defects. Inactivating PTH/PTHrP signaling disorders (iPPSD) define overlapping phenotypes based on their molecular etio...
Main Authors: | Tanguy Demaret, René Wintjens, Gwenaelle Sana, Joachim Docquir, Frederic Bertin, Christophe Ide, Olivier Monestier, Deniz Karadurmus, Valerie Benoit, Isabelle Maystadt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.928284/full |
Similar Items
-
Frequency of de novo variants and parental mosaicism in families with inactivating PTH/PTHrP signaling disorder type 2
by: Yerai Vado, et al.
Published: (2023-01-01) -
Editorial: Parathyroid disorders: updates of PTH/serum Ca2+ regulation and therapeutic prospects
by: Fan Zhang, et al.
Published: (2024-01-01) -
Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range
by: Fabio Medas, et al.
Published: (2019-04-01) -
Expressions of parathyroid hormone-related protein (PTHrP) and parathyroid hormone receptor-1 (PTH1R) in the condylar cartilage of temporomandibular joint modulated by occlusal elevation
by: Qianzhi Zhuang, et al.
Published: (2023-04-01) -
PTH/PTHrP activity and the programming of skeletal development in utero.
by: Tobias, J, et al.
Published: (2004)